SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients
Authors
Keywords
Epilepsy, Valproic acid, <em class="EmphasisTypeItalic ">SCN1A</em>, <em class="EmphasisTypeItalic ">SCN2A</em>, Antiepileptic efficacy
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-29
DOI
10.1007/s00228-019-02633-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The pharmacogenomics of valproic acid
- (2017) Miao-Miao Zhu et al. JOURNAL OF HUMAN GENETICS
- Simultaneous multi-gene mutation screening using SNPscan in patients from ethnic minorities with nonsyndromic hearing-impairment in Northwest China
- (2017) Shi-Hong Duan et al. Molecular Medicine Reports
- Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
- (2017) Julia Oyrer et al. PHARMACOLOGICAL REVIEWS
- Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy
- (2017) Iyan Younus et al. PHARMACOLOGY & THERAPEUTICS
- Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
- (2017) Lyndsey L. Anderson et al. Scientific Reports
- Beyond seizures — the importance of comorbidities in epilepsy
- (2016) Alberto Verrotti et al. Nature Reviews Neurology
- Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese
- (2016) Xi Li et al. PHARMACOGENOMICS
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Sodium Channels, Inherited Epilepsy, and Antiepileptic Drugs
- (2014) William A. Catterall Annual Review of Pharmacology and Toxicology
- Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy
- (2014) Chun-Lai Ma et al. PHARMACOGENOMICS
- SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness
- (2013) Ritu Kumari et al. BIOCHIMIE
- Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy
- (2013) Wenting Yun et al. EPILEPSY RESEARCH
- Therapeutic drug monitoring for tomorrow
- (2013) Erik Eliasson et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- SCN1A rs3812718 polymorphism and susceptibility to epilepsy with febrile seizures: A meta-analysis
- (2013) Linjun Tang et al. GENE
- SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis
- (2013) Batoul Sadat Haerian et al. PHARMACOGENOMICS
- SCN1A variations and response to multiple antiepileptic drugs
- (2013) T S C Yip et al. PHARMACOGENOMICS JOURNAL
- Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
- (2012) A. Brunklaus et al. BRAIN
- Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population
- (2012) Bo-Ting Zhou et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Effects of SCN1A and GABA Receptor Genetic Polymorphisms on Carbamazepine Tolerability and Efficacy in Chinese Patients with Partial Seizures: 2-Year Longitudinal Clinical Follow-Up
- (2012) Bo-Ting Zhou et al. CNS Neuroscience & Therapeutics
- Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates
- (2012) Valentina Zuliani et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study
- (2012) Batoul Sadat Haerian et al. PHARMACOGENOMICS
- A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy
- (2011) Ida Manna et al. EPILEPSIA
- Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker
- (2011) Emily V. Fletcher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization
- (2011) Chin-Chuan Hung et al. PHARMACOGENOMICS
- Molecular and Therapeutic Potential and Toxicity of Valproic Acid
- (2010) Sébastien Chateauvieux et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- NaV1.1 channels and epilepsy
- (2010) William A. Catterall et al. JOURNAL OF PHYSIOLOGY-LONDON
- Genetic factors associated with drug-resistance of epilepsy: Relevance of stratification by patient age and aetiology of epilepsy
- (2010) M. Blanca Sánchez et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression
- (2008) Patrick Kwan et al. Pharmacogenetics and Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started